Olaris featured in BiopharmaTrend Q&A article, "Hacking Metabolomics With AI To Improve Clinical Research"

"Hacking Metabolomics With AI To Improve Clinical Research" Check out Olaris CEO, Dr. Liz O'Day's, recent Q&A interview with BiopharmaTrend. Dr. O'Day explains how Olaris combines metabolomics, NMR and machine learning to further precision medicine. Read the full article here!

May 12, 2020

Olaris featured in BiopharmaTrend Q&A article, "Hacking Metabolomics With AI To Improve Clinical Research"